SCHEMBL19960271

SCHEMBL19960271

S=P(c1ccccc1)(c1ccccc1)c1ccc2c(c1)c1c3ccccc3ccc1c1nc3ccc(-c4ccc5ccc6cccc7ccc4c5c67)cc3n21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.35
KMT2A Q03164 2/20 0.32
CAMKK1 Q8N5S9 2/20 0.32
CAMKK2 Q96RR4 2/20 0.32
CYP1A2 P05177 2/20 0.32
MEN1 O00255 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
CASP1 P29466 1/20 0.32
CYP2C19 P33261 1/20 0.32
CASP7 P55210 1/20 0.32
ALDH1A1 P00352 2/20 0.31
HPGD P15428 2/20 0.31
KDM4E B2RXH2 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
CSNK2A1 P68400 1/20 0.31
PIM3 Q86V86 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960274 0.90 AHR (0.37) AHRKMT2ACAMKK1CAMKK2CYP1A2
SCHEMBL20090162 0.89 AHR (0.34) AHRKMT2ACAMKK1CAMKK2CYP1A2
SCHEMBL19960261 0.89 AHR (0.32) AHRKMT2ACAMKK1CAMKK2CYP1A2
SCHEMBL20090166 0.88 AHR (0.32) AHRKMT2ACAMKK1CAMKK2CYP1A2
SCHEMBL19960568 0.87 KMT2A (0.34) KMT2ACAMKK1CAMKK2CYP1A2MEN1
SCHEMBL19960279 0.87 ALDH1A1 (0.36) AHRKMT2ACAMKK1CAMKK2CYP1A2
SCHEMBL19960569 0.86 KMT2A (0.33) KMT2ACAMKK1CAMKK2CYP1A2MEN1
SCHEMBL20090180 0.84 KDM4E (0.33) AHRMAPTALDH1A1HPGDKDM4E
SCHEMBL20090168 0.84 ALDH1A1 (0.33) AHRKMT2ACAMKK1CAMKK2CYP1A2
SCHEMBL19965983 0.83 MAPT (0.42) AHRKMT2ACAMKK1CAMKK2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 AHR 58/4885KMT2A 443/4885CAMKK1 4412/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 AHR 58/4885KMT2A 443/4885CAMKK1 4412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.